PortfoliosLab logoPortfoliosLab logo
CADL vs. DOGZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CADL vs. DOGZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Candel Therapeutics, Inc. (CADL) and Dogness (International) Corporation (DOGZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CADL achieves a 55.75% return, which is significantly higher than DOGZ's -89.72% return.


CADL

1D
4.51%
1M
16.87%
YTD
55.75%
6M
75.30%
1Y
53.04%
3Y*
79.17%
5Y*
10Y*

DOGZ

1D
-1.80%
1M
-8.40%
YTD
-89.72%
6M
-90.05%
1Y
-95.96%
3Y*
-57.70%
5Y*
-49.50%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CADL vs. DOGZ - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CADL
Candel Therapeutics, Inc.
55.75%-34.91%490.48%-17.88%-77.11%11.71%
DOGZ
Dogness (International) Corporation
-89.72%-76.70%793.70%-74.03%-88.35%362.09%

Correlation

The correlation between CADL and DOGZ is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Jul 28, 2021

0.03

The correlation between CADL and DOGZ shifts across timeframes, from 0.03 (3 years) to 0.16 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CADL:

$548.78M

DOGZ:

$19.41M

EPS

CADL:

-$0.97

DOGZ:

-$0.83

PB Ratio

CADL:

3.98

DOGZ:

0.20

Total Revenue (TTM)

CADL:

$0.00

DOGZ:

$36.59M

Gross Profit (TTM)

CADL:

-$600.00K

DOGZ:

$7.70M

EBITDA (TTM)

CADL:

-$71.64M

DOGZ:

-$6.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CADL vs. DOGZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CADL
CADL Risk / Return Rank: 6565
Overall Rank
CADL Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
CADL Sortino Ratio Rank: 6666
Sortino Ratio Rank
CADL Omega Ratio Rank: 6363
Omega Ratio Rank
CADL Calmar Ratio Rank: 6868
Calmar Ratio Rank
CADL Martin Ratio Rank: 6363
Martin Ratio Rank

DOGZ
DOGZ Risk / Return Rank: 66
Overall Rank
DOGZ Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
DOGZ Sortino Ratio Rank: 66
Sortino Ratio Rank
DOGZ Omega Ratio Rank: 22
Omega Ratio Rank
DOGZ Calmar Ratio Rank: 11
Calmar Ratio Rank
DOGZ Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CADL vs. DOGZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Candel Therapeutics, Inc. (CADL) and Dogness (International) Corporation (DOGZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CADLDOGZDifference
Sharpe ratioReturn per unit of total volatility

+1.43

Sortino ratioReturn per unit of downside risk

+3.06

Omega ratioGain probability vs. loss probability

1.18

0.71

+0.47

Calmar ratioReturn relative to maximum drawdown

1.44

-0.99

+2.43

Martin ratioReturn relative to average drawdown

2.54

-1.30

+3.84

CADL vs. DOGZ - Sharpe Ratio Comparison

The current CADL Sharpe Ratio is 0.73, which is higher than the DOGZ Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of CADL and DOGZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CADLDOGZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.73

-0.70

+1.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

0.03

-0.35

+0.38

Drawdowns

CADL vs. DOGZ - Drawdown Comparison

The maximum CADL drawdown since its inception was -94.33%, smaller than the maximum DOGZ drawdown of -99.42%. Use the drawdown chart below to compare losses from any high point for CADL and DOGZ.


Loading charts...

Drawdown Indicators


CADLDOGZDifference

Max Drawdown

Largest peak-to-trough decline

-94.33%

-99.42%

+5.09%

Max Drawdown (1Y)

Largest decline over 1 year

-37.04%

-96.56%

+59.52%

Max Drawdown (3Y)

Largest decline over 3 years

-72.86%

-98.21%

+25.35%

Max Drawdown (5Y)

Largest decline over 5 years

-99.42%

Current Drawdown

Current decline from peak

-37.14%

-99.38%

+62.24%

Average Drawdown

Average peak-to-trough decline

-62.79%

-72.03%

+9.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.98%

73.64%

-52.66%

Volatility

CADL vs. DOGZ - Volatility Comparison

Candel Therapeutics, Inc. (CADL) has a higher volatility of 16.28% compared to Dogness (International) Corporation (DOGZ) at 15.25%. This indicates that CADL's price experiences larger fluctuations and is considered to be riskier than DOGZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CADLDOGZDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.28%

15.25%

+1.03%

Volatility (6M)

Calculated over the trailing 6-month period

53.92%

161.37%

-107.45%

Volatility (1Y)

Calculated over the trailing 1-year period

72.87%

137.18%

-64.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

167.21%

133.78%

+33.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

167.21%

120.69%

+46.52%

Dividends

CADL vs. DOGZ - Dividend Comparison

Neither CADL nor DOGZ has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CADL vs. DOGZ - Financials Comparison

This section allows you to compare key financial metrics between Candel Therapeutics, Inc. and Dogness (International) Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M202220232024202520260
7.71M
(CADL) Total Revenue
(DOGZ) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CADL and DOGZ have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CADL has higher volatility (16.28%) compared to DOGZ (15.25%). In terms of maximum drawdown, CADL dropped -94.33% vs DOGZ's -99.42%.

CADL currently has the higher Sharpe Ratio (0.73 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CADL and DOGZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer